Tulsa Cancer Center

12697 East 51st Street South
Tulsa, Oklahoma 74146

We've found

1 trials

at this facility

A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Tulsa, OK

Use our guide to learn which trials are right for you!